Browsing Tag

ExtensiveStage

Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for…

Eli Pacheco Jul 20, 2023 0

SHANGHAI, China, July 19, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical…

Health

COSELA® (Trilaciclib Hydrochloride for Injection) Now Approved in China to Decrease…

Eli Pacheco Jul 13, 2022 0

RESEARCH TRIANGLE PARK, N.C., July 13, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that the China National Medical…

Health

Tiragolumab Fails in Extensive-Stage Small Cell Lung Cancer

Eli Pacheco Jun 7, 2022 0

CHICAGO -- Combining the novel human anti-TIGIT monoclonal antibody tiragolumab with atezolizumab (Tecentriq) plus chemotherapy…

Health

New Real-World Data Show Potential of Trilaciclib to Reduce the Substantial Burden of…

Eli Pacheco Apr 1, 2022 0

RESEARCH TRIANGLE PARK, N.C., March 31, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced results of a retrospective,…

Health

Atezo-Chemo Benefit in Extensive-Stage SCLC Seen Outside Trials, Too

Eli Pacheco Oct 5, 2021 0

At the virtual European Society for Medical Oncology (ESMO) meeting, researchers explored the clinical…

Health

Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody…

Eli Pacheco Jul 23, 2021 0

China Oncology Focus, a subsidiary of Lee’s Pharm, has enrolled the first patient in the Socazolimab double-blinded Phase 3 study in combination with chemotherapy as a first-line treatment…